Barban V - Search Results

1

High stability of yellow fever 17D-204 vaccine: a 12-year restrospective analysis of large-scale production.

Barban V, Girerd Y, Aguirre M, Gulia S, Pétiard F, Riou P, Barrere B, Lang J. Barban V, et al. Vaccine. 2007 Apr 12;25(15):2941-50. doi: 10.1016/j.vaccine.2006.06.082. Epub 2006 Aug 1. Vaccine. 2007. PMID: 16914238

2

Broad neutralization of wild-type dengue virus isolates following immunization in monkeys with a tetravalent dengue vaccine based on chimeric yellow fever 17D/dengue viruses.

Barban V, Munoz-Jordan JL, Santiago GA, Mantel N, Girerd Y, Gulia S, Claude JB, Lang J. Barban V, et al. Virology. 2012 Aug 1;429(2):91-8. doi: 10.1016/j.virol.2012.03.007. Epub 2012 Apr 25. Virology. 2012. PMID: 22542002 Free article.

3

Yellow fever vaccine: comparison of the neurovirulence of new 17D-204 Stamaril™ seed lots and RK 168-73 strain.

Moulin JC, Silvano J, Barban V, Riou P, Allain C. Moulin JC, et al. Among authors: barban v. Biologicals. 2013 Jul;41(4):238-46. doi: 10.1016/j.biologicals.2013.04.005. Epub 2013 Jun 10. Biologicals. 2013. PMID: 23763825

4

Standardized quantitative RT-PCR assays for quantitation of yellow fever and chimeric yellow fever-dengue vaccines.

Mantel N, Aguirre M, Gulia S, Girerd-Chambaz Y, Colombani S, Moste C, Barban V. Mantel N, et al. Among authors: barban v. J Virol Methods. 2008 Jul;151(1):40-6. doi: 10.1016/j.jviromet.2008.03.026. Epub 2008 May 22. J Virol Methods. 2008. PMID: 18501437

5

Genetic stability of a dengue vaccine based on chimeric yellow fever/dengue viruses.

Mantel N, Girerd Y, Geny C, Bernard I, Pontvianne J, Lang J, Barban V. Mantel N, et al. Among authors: barban v. Vaccine. 2011 Sep 2;29(38):6629-35. doi: 10.1016/j.vaccine.2011.06.101. Epub 2011 Jul 13. Vaccine. 2011. PMID: 21745519

6

Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis viruses.

Guy B, Guirakhoo F, Barban V, Higgs S, Monath TP, Lang J. Guy B, et al. Among authors: barban v. Vaccine. 2010 Jan 8;28(3):632-49. doi: 10.1016/j.vaccine.2009.09.098. Epub 2009 Oct 4. Vaccine. 2010. PMID: 19808029 Review.

7

Evaluation of interferences between dengue vaccine serotypes in a monkey model.

Guy B, Barban V, Mantel N, Aguirre M, Gulia S, Pontvianne J, Jourdier TM, Ramirez L, Gregoire V, Charnay C, Burdin N, Dumas R, Lang J. Guy B, et al. Among authors: barban v. Am J Trop Med Hyg. 2009 Feb;80(2):302-11. Am J Trop Med Hyg. 2009. PMID: 19190230

8

17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005.

Barrett AD, Monath TP, Barban V, Niedrig M, Teuwen DE. Barrett AD, et al. Among authors: barban v. Vaccine. 2007 Apr 12;25(15):2758-65. doi: 10.1016/j.vaccine.2006.12.015. Epub 2006 Dec 28. Vaccine. 2007. PMID: 17368349

9

Evaluation of chimeric yellow fever 17D/dengue viral replication in ticks.

Kazimírová M, Mantel N, Raynaud S, Slovák M, Ustaniková K, Lang J, Guy B, Barban V, Labuda M. Kazimírová M, et al. Among authors: barban v. Vector Borne Zoonotic Dis. 2012 Nov;12(11):979-85. doi: 10.1089/vbz.2011.0947. Epub 2012 Aug 27. Vector Borne Zoonotic Dis. 2012. PMID: 22925017

10

Improvement of the Dengue Virus (DENV) Nonhuman Primate Model via a Reverse Translational Approach Based on Dengue Vaccine Clinical Efficacy Data against DENV-2 and -4.

Barban V, Mantel N, De Montfort A, Pagnon A, Pradezynski F, Lang J, Boudet F. Barban V, et al. J Virol. 2018 May 29;92(12):e00440-18. doi: 10.1128/JVI.00440-18. Print 2018 Jun 15. J Virol. 2018. PMID: 29593041 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters